BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10805933)

  • 1. Susceptibility of human herpesvirus 6 to antiviral compounds by flow cytometry analysis.
    Manichanh C; Grenot P; Gautheret-Dejean A; Debré P; Huraux JM; Agut H
    Cytometry; 2000 Jun; 40(2):135-40. PubMed ID: 10805933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of antiviral efficacy against lymphotropic herpesviruses utilizing flow cytometry.
    Long MC; Bidanset DJ; Williams SL; Kushner NL; Kern ER
    Antiviral Res; 2003 Apr; 58(2):149-57. PubMed ID: 12742575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6.
    Reymen D; Naesens L; Balzarini J; Holý A; Dvoráková H; De Clercq E
    Antiviral Res; 1995 Dec; 28(4):343-57. PubMed ID: 8669893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A method for detection of HHV-6 antigens and its use for evaluating antiviral drugs.
    Yoshida M; Yamada M; Chatterjee S; Lakeman F; Nii S; Whitley RJ
    J Virol Methods; 1996 Apr; 58(1-2):137-43. PubMed ID: 8783159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric evaluation of antiviral agents against human herpesvirus 6.
    Amjad M; Gillespie MA; Carlson RM; Karim MR
    Microbiol Immunol; 2001; 45(3):233-40. PubMed ID: 11345533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent advances in antiviral drugs--antiviral agents to HCMV, HHV-6, and HHV-7].
    Takahashi K
    Nihon Rinsho; 1998 Jan; 56(1):140-4. PubMed ID: 9465679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of antiviral compounds against human herpesvirus 6 and 7.
    Yoshida M; Yamada M; Tsukazaki T; Chatterjee S; Lakeman FD; Nii S; Whitley RJ
    Antiviral Res; 1998 Dec; 40(1-2):73-84. PubMed ID: 9864048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of susceptibility of human herpesvirus 8 to antiviral drugs by quantitative real-time PCR.
    Sergerie Y; Boivin G
    J Clin Microbiol; 2003 Aug; 41(8):3897-900. PubMed ID: 12904413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro efficacy of ganciclovir, cidofovir, penciclovir, foscarnet, idoxuridine, and acyclovir against feline herpesvirus type-1.
    Maggs DJ; Clarke HE
    Am J Vet Res; 2004 Apr; 65(4):399-403. PubMed ID: 15077679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral drug susceptibility of human herpesvirus 8.
    Neyts J; De Clercq E
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2754-6. PubMed ID: 9420052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus.
    Medveczky MM; Horvath E; Lund T; Medveczky PG
    AIDS; 1997 Sep; 11(11):1327-32. PubMed ID: 9302441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitro.
    Williams-Aziz SL; Hartline CB; Harden EA; Daily SL; Prichard MN; Kushner NL; Beadle JR; Wan WB; Hostetler KY; Kern ER
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3724-33. PubMed ID: 16127046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral activities of nucleosides and nucleotides against wild-type and drug-resistant strains of murine cytomegalovirus.
    Smee DF; Barnett BB; Sidwell RW; Reist EJ; Holy A
    Antiviral Res; 1995 Jan; 26(1):1-9. PubMed ID: 7741517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options.
    Reusser P
    J Hosp Infect; 1996 Aug; 33(4):235-48. PubMed ID: 8864937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the catalytic subunit of the human herpesvirus 6 (HHV-6) DNA polymerase expressed in an in vitro transcription/translation assay.
    De Bolle L; Balzarini J; De Clercq E; Naesens L
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):999-1001. PubMed ID: 14565330
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro and in vivo inhibition of murine gamma herpesvirus 68 replication by selected antiviral agents.
    Neyts J; De Clercq E
    Antimicrob Agents Chemother; 1998 Jan; 42(1):170-2. PubMed ID: 9449280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of antiviral activity against human herpesvirus 8 (HHV-8) and Epstein-Barr virus (EBV) by a quantitative real-time PCR assay.
    Friedrichs C; Neyts J; Gaspar G; De Clercq E; Wutzler P
    Antiviral Res; 2004 Jun; 62(3):121-3. PubMed ID: 15130535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8.
    De Clercq E; Naesens L; De Bolle L; Schols D; Zhang Y; Neyts J
    Rev Med Virol; 2001; 11(6):381-95. PubMed ID: 11747000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibility of six isolates of equine herpesvirus 1 to acyclovir, ganciclovir, cidofovir, adefovir, PMEDAP and foscarnet.
    Garré B; van der Meulen K; Nugent J; Neyts J; Croubels S; De Backer P; Nauwynck H
    Vet Microbiol; 2007 May; 122(1-2):43-51. PubMed ID: 17276631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a cidofovir-resistant HHV-6 mutant obtained by in vitro selection.
    Bonnafous P; Boutolleau D; Naesens L; Deback C; Gautheret-Dejean A; Agut H
    Antiviral Res; 2008 Mar; 77(3):237-40. PubMed ID: 18241936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.